According to Harvard Bioscience's latest financial reports the company's current earnings (TTM) are -A$14.15 M. In 2023 the company made an earning of -A$3.84 M an increase over its 2022 earnings that were of -A$13.77 M.The earnings displayed on this page is the company's Pretax Income.